A Study of LXI-15029 in Patients With Advanced Malignant Solid Tumors
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: LXI-15029|DRUG: LXI-15029+Exemestane
Sponsor: Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.